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ABSTRACT

The hypothesis that solid particles may be encapsulated by
coacervation led to the investigation of the extractability of microcapsules,which contained solids, by gastrointestinal fluids.

Starting

pH, starting temperature, ratio of solid to encapsulating materials,
quantity of denaturant, and final pH were varied.

In a ddition a sur-

factant and dispersant were added to selected series.

The effects

of the variables and additives on microcapsules were determined by
submitting samples to simulated gastrointestinal fluids for periods

(

of up to two and one-half hours and then comparing the extracts
spectrophotometrically to know absorption spectra.

Results

showed that all variables and additives effected some degree of
change in microcapsules.
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I.

INTRODUCTION

The term coacervation has had a long and diversified history.
It was used as early as 1398 to mean, "a 'heaping together,

people or things' (1).

1

either of

It has more recently been adopted by chemists

to describe the salting out of a lyophilic solid into liquid droplets
rather than solid aggregates (2).

The term was first introduced into

colloidal chemistry by Kruyt and Bungenberg de Jong (3) to describe
the flocculation or separation of liquids from solution when at least
one of the liquids contained a macromolecular or colloidal solute.
Coacervation has been sub-divided by Bungenberg de Jong (4) into
simple coacervation and complex coacervation; simple coacervation
describes a system which requires that only one colloidal solute be
present, while complex coacervation describes a system containing
more than one colloid.
According to this same author (5) simple coacervation is the aggregation or flocculation of a dispersed hydrophilic colloid brought
about by the addition of a strongly hydrophilic substance, to produce
a water deficit in a part of the system.

Simple coacervation can be

accomplished by mixing two colloidal dispersions each of which contains a concentration of colloid from approximately 20 to 40 per cent;
o,r it can be induced in a dispersion of a less concentrated, single

6

7

(

colloid by adding alcohol, sodium sulfate, or resorcinol.

In either

case, it is possible to redisperse the aggregated colloidal droplets by
the addition of water.

Neither the isoelectric point of the colloid nor

the presence of indifferent salts is of any significance to the process
of simple coacervation; the principal requirement here is merely the
creation of an insufficiency of water in a part of the total system (6).
Complex coacervation can be induced in systems having two dispersed hydrophilic colloids of opposite electrical charges.

Bungenberg

de Jong stated that, in a system of gum arabic and gelatin, complex
coacervation always occurs at pH values below the isoelectric point of
the gelatin and maintained that this was true "however one changes the
other factors" (7).
He explained that the apparent equivalent weight of the gelatin and
gum arabic depended on the isoelectric point of the gelatin and the pH
of the system (derived from the dissociation of the carboxyl groups).
The optimum pH for complex coacervation was that pH at which equivalents of oppositely charged micelles were present, since at that point
the greatest possible number of salt bonds were formed and the highest
degree of coacervation occurred.

Therefore, in such a system, the pH

should be adjusted so that the gelatin particles are positive, since gum
arabic particles are always negative in colloidal dispersion: {$.).
It was also observed that the practical limits of concentration of
each colloid, within which complex coacervation occurred, were between O. 001 and 5 per cent (9).

The upper limit was explained by the

8
(

presence of the indifferent salt, calcium chloride, derived from calcium
and chloride ions present in acacia and gelatin, respectively.

Indifferent

salts, such as calcium chloride, hinder coacervation because of the
"double valency rule 11 (10).
Although simple and complex coacervation yield essentially the
same type of products, the conditions necessary for the agglomeration
of each of them differ considerably.

When all of the factors are con-

sidered, the principal condition for simple coacervation becomes an
insufficiency of water in part of the system.

Complex coacervation,

however, will not occur even if the concentration of colloids falls within the prescribed limits and the indifferent salt concentration is sufficiently low.

The principal condition required for complex coacerva-

tion is adequate opposition of charge between two colloids, which can
be brought about by adjustment of pH.

Minimal hydration of ions, the

required condition for simple coacervation, is accomplished by the removal of water.

Since pH can be precisely adjusted, and since the

hydration process is more difficult to control, this study was concerned
primarily with microencapsulation using complex coacervation.
Green and Schleicker ( 11) have made practical use of coacervation
in a patented process of microencapsulation.

In this process, capsules

were formed either by the reaction of two oppositely charged dispersed
colloids or by precipitation of one dispersed colloid through the action
of a strongly hydrophilic substance.

Although encapsulation using a

9
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single colloid was not carried out e x per:iine n tally, it should be noted that
procedures for such entrapment are to be f ou nd in t h e United States
Patents: No. 2,730 , 457 (11) , No. 2,712 , 50 7 (12), No. 2,730,456 (13),
No. 2, 800, 456 (14), No. 28, 800, 458 (15) , No. 3, 137, 631 (16), and
No. 3, 155, 590 (17).
Various patents issued to Green and Schleicker ( 13, 18) indicate
that paraffin oil, castor oil, sperm oil, lard oil, methyl salicylate,
and trichlorodiphenyl have been entr apped in ge l a tin-acacia microcapsules.

At least some of the oils contained dissolved substances, such

as Sudan III dye, crystal violet lactone, malachite green lactone, and
benzoyl leuco methylene blue.

(

It is interesting t o note that these patent

holders claimed to be able to coacervate with concentrations of gelatin
and gum arabic up to 14 per cent.

The ability to coacervate at con-

centrations in excess of 5 per cent may have been due in part to the
nucleating power of the oil droplets present in this system, which
were not present in the Bungenberg de Jong system.
The process by which oils were encapsulated by Green and
Schleicker was relatively simple.

Dispersions of gelatin and acacia

in water were made at 55°C. and the pH of each was adjusted to a
value just below the isoelectric point of th e gelatin.

An oil-in-water

emulsion was then formed using the acacia and/or gelatin dispersions
as the emulsifying medium.

When only one of th e colloidal dispersions

was included in the emulsifying medium., t h e s e c ond dispersion was

10
(
I

added following completion of emulsificat ion.

The n, the pH was ad-

justed to a value even farther below the isoelectric point of t he gelatin
and a solution of formaldeh yde in water was added .

Then , the tempera-

ture was reduced from 5 o0 c. to 1 o0 c. and the pH was raise d to a value
above the isoelectric point of the gelatin.

The viscosity was adjusted

by evaporation or by addition of water, to prepare the product for its
ultimate use.

The authors pointed out that the product could be pre-

pared as a free flowing powder, either by spray or oven drying.
Conditions for encaps ulation of oils other tha n those mentioned above
were not given, nor was a method to evaluate the strength or deg ree of
encapsulation elucidated (11, 13).
Luzzi and Gerraughty (18), in a study to determine the permeability
of the capsule wall, assayed microcapsules containing modified mineral
oil.

The mineral oil was modified so that it possessed a range of

saponification values and acid values, as well as surfactant properties.
The samples were extracted, for varying periods of time, using ethyl
ether; the liquid extracts were diluted with the solvent and assayed for
oil content by spectrophotometric means.

It was found that , although

saponification value had little effect upon the permeability of the capsule wall, higher acid values and surfactants increased wall permeability.
Miller and Anderson (1 7) , using a system of cyclohexane , butyl
rubber, aspirin, and ethyl cellulose prepared a sustained action, solid

11
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dosage form of aspirin.

The authors claim a 92% aspirin content for

their product; however, the assay method they use d was not disclosed.
This system may be thought of as encapsulation by means of simple_
coacervation, since it relied on the solubility of the encapsulating
agent as a function of variable temperature.

The authors have con-

trolled the apparent required amount of solvent through variation of
temperature as Bungenberg de Jong controlled available water by salt
content.
Phares and Speradino (19), in a summary, state, "Almost any
insoluble particle can be coated with coacervate drops.

11

The authors

of Microcapsulation (20) enumerate several solid and liquid materials
I

\

which have been encapsulat ed by coacervation.

None of these sources,

however, makes an attempt at predicting the rate at which the encapsulated substance will be released.
In pharmacy, as well as in other areas (20), encapsulation
through coacervation has great potential practical application.

Some

properties of these microcapsules which would be es pecially useful
to pharmacy include: the ability to prevent vaporization of any volatile
substances ( e. g. , peppermint oil); the ability to protect moisture
sensitive and light sensitive substa nces (e.g., vitamins A and K); the
ability to separate physically incompatible materials within a single
system; the ability to disperse water -in soluble substances more
readily in an aqueous medium; and, the ability to prolong the action

12
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of certain drugs when they have been ingested.
The effectiveness of a drug is dependent, above all, upon its
availability to the body.

A substance which is encapsulated is not

immediately available.

The capsule wall must be penetrated or must

be conducive to a leaching action, or both.

In either case, deviations

from the prescribed method of microcapsule manufacture, along with
suitable assay methods, should be investigated and the results considered when a pharmaceutical dose form is to be prepared.

This is

especially applicable when the drug is to be embodied in a sustained
or prolonged release type of medication.
With these considerations in mind, the system of Luzzi and

(

Gerraughty (18) was examined.

It was the intention of this study to

develop a means to encapsulate solids through complex coacervation
and to determine:
( 1) the effects of varying the starting pH, the starting temperature, the quantity of denaturant, the ratio of material to be encapsulated to encapsulating agents, the final pH, and the effect of certain
surfactants and deflocculants on the permeability of capsule shell when
in contact with gastrointestinal fluids; and
(2) to develop a method for the evaluation of the effect of such
variation on the system.

This study was designed so that the suscep-

tibility of the capsule wall to the action of gastrointestinal fluids could
be determined.

(
II .

EXPERIMENTA L

PREPARA T IO N OF MICROCAPSULES
Th e basic procedure employed by Luzzi and Gerraughty (18 ) for
the preparat ion of microcapsules was used .

The primary enc apsulat -

ing solution s we r e m a de by dissolving 3 . 0 Gm. of acacia and 3. 0 Gm .
of gelatin separ ate l y in 100 m l. of pur·'fied water at 55°C .

The acacia

used was pow d ered A c acia , U . S. P .; the gelatin used was 3 0 0 blo om
pigskin gelatina w i th an isoelectric point at pH 8 . 0.
A 20% sodium hydroxide solution was used to adjust the starting
pH of the solutions t o 6. 5 .

(

A c acia particles in solution are negative l y

charged and a t t h i s p H the gel atin particles are sufficiently negative
so that they will not i nteract with the acacia.
An emulsion was formed by a d ding 12 ml. of oil to the a cacia
solution.

The g elat in s o lution was then added to the emulsi o n , with

gentle stirring.
The pH of t he m ixture was then adjusted to 4 . 5 by the d r o pwise
addition of Dilute d Hyd rochloric Acid , U . S . P ., while stirring .

At

this pH, the ge latin p articles were positively charged and were attracted to the n egative acacia particles .

The combined particles

coalesced about t he oil droplets c.nd i solated them from the re st of the

(a)

T he Ame r i can Agricultural Chc:mical Company , Detroi t , M i chigan
13
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system.
At this point, 10 ml. of Formaldehyde Solution, U.S. P., were
added to the mixture and it was cooled to 1 o0
ice bath.

c.

by immersion in an

The pH was then adjusted to a final pH of 9. 0 by the drop-

wise addition of 20% sodium hydroxide solution.

The addition of the

formaldehyde denatured the coagulated gelatin-acacia complex and entrapped the oil droplets more permanently than before.
coacervate helped to set the gelatin-acacia
permeable.

film~

Chilling of the

making it even less

The pH adjustment also enhanced this effect.

The mixture was then diluted to approximately 400 ml. with distilled water and then filtered through filter paper.

The wet mass was

firmly wrapped in blotting paper to remove some of the excess moisture.

The resulting soft, rubbery mass was then passed through a

20 mesh screen and dried at 50°C. for 24 hours.

The dilution of the

mixture facilitated filtration and allowed removal of some of the excess formaldehyde.

The precipitate, after being dried, was coarsely

granular.
The above procedure was altered in the following ways:
( 1) the starting pH was varied between 5. 0 and 7. O;
(2) the ratio of mate r ial to be encap sulated to encapsulating
materials (dry weight) was varied from 2 / 6 through 20 /6;
(3) the quantity of formaldehyde solution was varied from
1 ml. to 20 ml. for each 100 ml. of 3% gelatin dispersion;

15
(4) the starting temperature was varied from 34°C. to 42°c.;
(5) the final pH was varied from 6. 5 to 8. 8; and,
(6)

solid particles, all of which passed through a U.S. P. 60 mesh

screen, rather than oil droplets, were encapsulated.
In addition, Tween 20 and Darvan 7 were added in various quantities to the aqueous phase prior to the addition of the solid.

In order to

minimize the degradation of pentobarbituric acid, the temperature at
which the capsules were dried was reduced from 50°C. to 40°C.

All

data reported in the section dealing with results are averages of duplicate determinations of two or more samples.

{

CHOICE OF MATERIALS
The primary objective of this research wa s to determine whether
or not a solid particle could be encapsulated by this particular process .
Preliminary investigation brought forth the facts that:
(1) the solid to be encapsulated should be insoluble, or nearly so,
iri the system;
(2) the solid particles should be readily dispersible in either
gelatin or acacia solution;
(3) the solids should contribute no surfactant qualities;
(4) the solid should be quickly soluble when e xposed to the
proper solvent;
(5) the solid should not degrade appreciably when exposed to

.

'
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aqueous systems for several hours;
(6) the solid should preferably be of a pharmaceutical nature.
The following solids were chosen and encaps u lated:

colloidal

sulfurb, special flowers of sulfurc, aspirin anhydride (recrystallized from ethyl acetate solution to a M. P. of 81°c. -83°C. )d, Acetophenetidin, U.S. P., barbituric acide, lycopodium sporese, DDTf,
pentobarbituric acid (M. P. 127°-128°c. )g, and carbon blackh.
Since sulfur was available in a variety of p a rticle sizes and because it seemed to conform to all of the other requirements, several
samples of microcapsules containing it were prepared.

However, con-

'

siderable difficulty was encountered when attempts were made to assay

(

the sulfur capsules.

Although it first appeared that sulfur could be

assayed by a simple gravimetric method, it was found that when it was
encapsulated and still wet from immersion in gastrointestinal fluids,
the sulfur was, at best, only slowly extractable by carbon disulfide,
This was true even when the capsules were previously crushed by
mechanical means.

SulfidalR, Heyden Chemical Corp., New York 17, New York
Stouffer Chemical Co., 380 Madison Ave., New York 17, New York
The Upjohn Co., Kalamazoo, Michigan
Amend Drug and Chemical Co., 117 East 24th St., New York, 10,
New York
(£) 1, 1, l-trichloro-2, 2-bis (p-chlorophenyl) ethane, Technical
Grade, Matteson, Coleman & Bell, East Rutherford, New Jersey
(g) "Acid Nembutal," Abbott) Laboratories, North Chicago, Illinois
(h) "UCET" Acetylene Black 50% Compressed, Union Carbide Corp. ,
Olefin Division, 270 Park Ave., New York, New York
(b)
(c)
(d)
(e)

17
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Aspirin anhydride offered the advantages that it was less soluble than acetylsalicylic acid and that a prolonged release dosage form
would probably prove commercially valuable.

However, its stability

to hydrolysis was not sufficient for the conditions of this project.
Lycopodium spores and carbon black were encapsulated in an
attempt to obtain more informative photomicrographs.

However,

neither of these substances could be assayed by a simple method.
DDT, on the other hand, would have had to be extracted (as was
sulfur) from aqueous media to a non-aqueous media before assays
could be carried out.
The choice was therefore narrowed to barbituric acid and
pentobarbituric acid,

In the case of both barbiturates the advantage

was apparent from the fact that both were insoluble in acid aqueous
media but soluble, as their salts, i:Q. alkaline aqueous media.
Since, at that time, an in-vivo assay was contemplated and because the hypnotic effect of pentobarbituric acid is shorter than
that of barbituric acid, the former, rather than the latter, was
chosen to demonstrate the effect of the variables discussed earlier.
This choice, however, limited the range over which certain of the
variables could be tested.

It became obvious, for example, that

the starting hydrogen ion concentration must be kept above that
at which significant quantities of pentobarbituric acid would be
soluble.

18
METHOD OF EVALUATION OF MICROCAPSULES
The method used to evaluate the susceptibility of the coacervate
shell to the action of U.S. P. simulated gastrointestinal fluidsi was
based principally on the ability of the fluids to expose and/ or extract
the encapsulated material.

In order to determine the degree of des-

truction or permeability, or both, caused by the gastrointestinal fluids,
a spectrophotometric method of assay was devised.
The microcapsules were prepared in the manner previously described and 0. 25 Gm. samples of the dried capsules were exposed to
gastric and intestinal fluids.

The samples were fir st exposed con-

secutively, then separately to 100 ml. of gastric fluid and 100 ml. of
intestinal fluid, employing a Burrell Wrist Action Shakerj.
In the first instance, the samples remained in contact with 100 ml.
of gastric fluid for O. 5 hours, were filtered, and the filter paper and
remaining sample were then transferred to 100 ml. of intestinal fluid;
the filter paper was broken up prior to immersion in intestinal fluid .
A 1. 0 ml. sample was withdrawn through a cotton pledget after one hour
exposure to intestinal fluid and, after two hours, the intestinal fluid
was removed from the sample by filtration.
In the second instance, the samples were allowed to remain in contact with the gastric fluid for O. 5 hours.

Duplicate samples were

(i) U.S. P. XVI, pp. 1072-73
(j) Burell Corp., Pittsburg, Pennsylvania

19
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prepared and allowed to remain in contact with intestinal fluid for onehalf and one hour periods.
The removal of the sample from gastrointestinal fluids was preceded in each instance by the adjustment of pH to 9. 25.

If the sample

were to remain in a fluid for further extraction, the pH was again adjusted to official (U.S. P.) suggested values for that fluid.

Diluted

Hydrochloric Acid, U.S. P. and 20% sodium hydroxide solution were
used for the adjustments.
Pentobarbituric acid has a pKa of 8. 11 (21) and, therefore, at
pH 9. 1 the ratio of sodium pentobarbital to pentobarbituric acid becomes ten to one.

Spectrophotometric studies of solutions of sodium

pentobarbital indicated that adsorption increased with increased pH
values and that at pH 9. 0, as may be predicted by theory, a gradual
decrease in the slope of the curve occurred.

Since pH values of 9. 25

co\,lld be achieved with relative accuracy (+ 0. 05 pH units) and ease,
and since a great majority of the solute is in the salt form at this pH,
this was the pH at which all liquid filtrates were compared.
The liquid filtrates, after exposure to the gastric fluid, were
assayed for content of active constituent as were the liquid filtrates
after exposure to intestinal fluid.

The solutions were scanned for

wavelength of maximum absorption using a recording spectrophotometerk. A broad peak was found with a maximum at 241 to 242 mJ'(.

(k)

Bausch & Lomb "Spectronic 505, "Bausch & Lomb Optical Co.
Rochester, New York

,

20
(

Beer's Law plotsl were prepared using a B e ckman spectrophotometerm.
The concentration of the liquid filtrates obtained by the extraction
methods already described, were determined by comparing their respective Beer's Law plots to the absorbance observed.
The total quantity of pentobarbituric acid in each sample was found
by disintegrating a known weight of capsules in a Virtis blendern with a
known volume of distilled water at pH 9. 2 5, the sample was filtered and
the resulting liquid adjusted, if necessary, to pH 9. 25 .

Aliquots were

prepared and spectrophotometric data w ere collect e d which, when
compared to the Beer's Law Plot of Figure III (p. 2 3 ), yielded the information from which the calculations for total pentobarbituric acid
content were carried out.

(1)

See figures on pages 21, 22 and 23.
Beckman D. U. Spectrophotometer, Beckman Instruments, Inc.,
Fullerton, California
(n} Virtis 11 45," Precise Products Corp. , Racine, Wisconsin

(m)
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III.

RES ULTS

EFFECT OF STARTING@ ON MICROCAPSULES
Each sample in this series was prepared by a method designed
to determine the effects of different starting hydrogen ion concentrations on the microencapsulation of pentobarbituric acid.

That is, all

aspects of the preparation of each sample remained constant throughout
with the exception that the starting pH was varied from pH 5. 0 through
pH 7. O.
Two factors were primarily responsible for the choice of thes e
limits.

Firstly, it was observed that systems prepared using only

gelatin and acacia be.came slightly cloudy even at pH values just above
pH 5. 0, an indication that the point of complete coacervation was being
approached so that the lowest practical starting pH was established to
be 5. 0.

Secondly, since the salt-acid ratio of sodium pentobarbital-

pentobarbituric acid increased from 1. 26 at pH 7. 0 as the pH incre ased
and since the salt was soluble in alkaline aqueous media, the examination of microencapsulation at starting pH values greater than 7. 0 was
not practical.
A series of s amples ranging from pH 5. 0 to pH 7. 0 was prepared
and 0. 25 Gm. of each were assayed in the manner previously described.

Table I shows that, throughout the entire series, the maximum
24
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TABLE I
EFFECT OF STAR TING pH ON THE

% OF PENTOBARBITURIC

ACID EXTRACTED FROM MICROCAPSULES EXPOSED
TO GASTROINTESTINAL FLUIDS*

Starting pH

after 1 /2
hr. in
gastric
fluid

after 1
hr. in
intestinal
fluid

after 2
hrs. in
intestinal
fluid

total in
gastric and
intestinal
fluids

5.0

33.8

15. 9

24.0

57.8

5.3

27.0

14.8

26.9

53.9

6.0

30. 1

13. 3

23.6

53.7

6.

5

23. 7

10.9

29.3

53.0

7.0

30.5

13. 3

24.0

54.5

*All values expressed as
in microcapsules.

% of

total pentobarbituric acid found

Note: After removal of gastric fluid the samples were transferred to intestinal fluid.

l
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difference in per cent of total of pentobarbituric acid released after 2. 5
hours of exposure to gastro-intestinal fluids was only 4. 8.

The differ-

ence in per cent released was somewhat greater (9. 9) after one-half
hour exposure to gastric fluid alone,

Table II indicates that after one

hour exposure to intestinal fluid the maximum difference in total per
cent released was 3. 1.

Under all the test conditions, the samples

seemed to remain in the same relative positions with respect to acid
released.

EFFECT OF STARTING TEMPERATURES ON MICROCAPSULES
Gelatin-acacia systems, in the concentrations used for this project, became gels at slightly above room temperature but became less
viscous as the temperature of the systems was raised,

For this reason

and since the solubility of pentobarbituric acid increased with increasing temperature, it was desirable to examine the effects on microencapsulation by' varying the starting temperature.
Tables III and IV show that the range of starting temperatures
employed was between 34°C. and 42°C.

In all cases observed, except

after 0, 5 hours in gastric fluid, the per cent of pentobarbituric acid
that was released was found to be at a maximum at 34 °C. starting
temperature and reached a minimum at 37°C. starting temperature.

EFFECT OF RATIO OF SOLID TO ENCAPSULATING MATERIALS
During preliminary studies, microscopic examination of micro-

(

TABLE II
EFFECT OF STARTING pH ON THE% OF PENTOBARBITURIC
ACID EXTRACTED FROM MICROCAPSULES EXPOSED
TO INTESTINAL FLUID*

Starting pH

after 1 /2 hr.

after 1 hr.

5.0

27. 5

28.0

5. 3

2 5. 8

24.5

6.0

18.4

26.5

6.

5

22.4

24.9

7.0

2 5. 3

25.2

*All values expressed as % of total pentobarbituric acid found
in microcapsules.

\
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TABLE III
EFFECT OF STAR TING TEMPERATURE ON THE

% OF

PENTO-

BARBITURIC ACID EXTRACTED FROM MICROCAPSU LES
EXPOSED TO GASTROINTESTINAL FLUIDS*

Starting
Temperature (oc.)

34

after 1 /2
hr. in
gastric
fluid

after 1
hr. in
intestinal
fluid

after 2
hrs. in
intestinal
fluid

total in
gastric and
intestinal
fluids

44.3

24.4

27.6

71. 9

(

36

37.8

16.4

25.3

63. 1

37

36.8

13.2

22.0

58.8

40

34.8

19.2

26.3

61. 1

42

38.8

18.9

26.8

65.6

*All values

expressed as
in microcapsules.

% of

total pentobarbituric acid found

Note: After removal of gastric fluid the samples were transferred to intestinal fluid.
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TABLE IV
EFFECT OF STARTING TEMPERATURE ON THE% OF PENTOBARBITURIC ACID EXTRACTED FROM MICROCAPSULES
EXPOSED TO INTESTINAL FLUID*

Starting Temperature

after 1/2 hr.

after 1 hr.

34

32.4

35.6

36

28. 3

32.9

37

25. 6

30.8

40

27. 9

33. 1

42

2 9. 8

35.0

*All values expressed as
in microcapsules.

% of total pentobarbituric acid found
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capsule systems revealed what appeared to be unfilled coacervate droplets (Photograph III, page 51 ).

This observation, together with the

assumption that there may be a practical limit to the quantity of a solid
that can be added to a given system, prompted examination of systems
employing different ratios of solids to encapsulating agents.

The re-

sults arrived at, using starting temperature as a variable, proved to
be the most predictable.

The series consisted of ratios ranging from

4. 0 Gm. of pentobarbituric acid to 6 Gm . tota l dry weight of encapsulating materials (4/6), through 20, 0 Gm. of acid to 6 Gm. total dry
weight of encapsulating materials (20/6).

With the exception of the

variable, as noted, all conditions within a series remained unchanged.
Tables V and VI show that, after assay, the per cent of total acid which
was released from the samples increased as the ratio of solid to encapsulating material increased.

Table V, it should be noted, also shows

that the increase in per cent released, from one to two hour exposures
to intestinal fluid, decreased as the ratio increased.

EFFECT OF DIFFERENT QUANTITIES OF DENATURANT ON MICROCAPSULES
To determine the effects of varying quantities of denaturant added
to the system, a series of samples was prepared in which the volume
of 37% formaldehyde solution was varied from one to 20 ml. for each
100 ml, of 3% gelatin solution,

All other aspects of preparation were

maintained constant throughout the series.

(
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TABLE V
EFFECT OF RATIO ON THE% OF PENTOBARBITURIC ACID
EXTRACTED FROM MICROCAPSULES EXPOSED TO
GASTROINTESTINAL FLUIDS*

Ratio

after 1 /2
hr. in
gastric
fluid

after 1
hr. in
intestinal
fluid

after 2
hrs. in
intestinal
fluid

total in
gastric and
intestinal
fluids

4/6

28.7

13. 3

24.0

42.7

8/6

36.8

13.2

22.0

58.8

12/6

39. 1

18.4

26.6

65.7

16/6

40. 2

26. 1

30.7

70.9

20/6

45. 2

26.2

2 9. 1

74.3

*All values expressed as
in microcapsules.
Note:

% of

total pentobarbituric acid found

after removal of gastric fluid the samples were transferred to intestinal fluid.
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TABLE VI
EFFECT OF RATIO ON THE

% OF PENTOBARBITURIC ACID

EXTRACTED FROM MICROCAPSULES EXPOSED TO
INTESTINAL FLUID*

----- -- --- -- ----------------- ------ ----

-------- --------------~---------- --

Ratio

after 1 /2 hr.

after 1 hr.

-4/6

26.6

28.2

8/6

25. 6

31. 2

12/6

39.5

38.5

16/6

35.5

41. 2

20/6

41. 4

52.3

------*An values expressed as
in microcapsules.

% of

32

total pentobarbituric acid found
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Formaldehyde acts as a denaturant to harden and fix in place the
wet gelatinous shell; and in order to test this effect microencapsulation
was attempted within the stated range.

Tables VII and VIII show that

1 ml. and 2 ml. quantities of the formaldehyde solution were insufficient to effect collection of the samples.

At a volume of 4 ml. of

formaldehyde solution the samples became collectable and continued
to be collectable throughout the remaining range of the series.

An in-

teresting observation is that, during initial exposure to either gastric
or intestinal fluids, the per cent of pentobarbituric acid released from
the capsules was greatest in those samples to which the largest quantity of formaldehyde had been added.

Table VII also shows that when the

samples were transferred from gastric fluid to intestinal fluid the
quantity of acid which was found in the latter decreased with increasing
quantities of formaldehyde.

EFFECT OF FINAL

.EB

ON MICROCAPSULES

Pentobarbituric acid is very soluble at pH values greater than
8. 0, and is also relatively insoluble at acid pH values.

Considering

that a pH value of 9. 0 was previously considered optimum (18) for the
final pH, it was desirable to determine what effect would occur if the
final pH was varied.
A series of samples was prepared with final pH values ranging
between 6. 5 and 8. 8.

Tables IX and X show that after initial exposure

(

TABLE Vll
EFFECT OF FORMALDEHYDE ON THE% OF PENTOBARBITURIC
ACID EXTRACTED FROM MICROCAPSULES EXPOSED TO
GASTROINTESTINAL F'LUIDS*

Formaldehyde
Solution
(ml.)

(

after 1 /2
hr, in
gastric
fluid

after 1
hr. in
intestinal
fluid

after 2
hrs . in
intestinal
fluid

total in
gastric and
intestinal
fluids

1

sample not collectable

-

2

sample not collectable

-

4

40.2

22.6

30.0

70.2

6

38. 0

16. 6

26.8

64.8

8

32. 9

17. 3

26.4

59.3

10

37.8

16. 4

25,3

63, 1

20

47.8

18. 2

23,8

71. 6

*All values

expressed as
in microcapsules,

% of

-

-

-

-

-

-

-

-

-

total pentobarbituric acid found

Note: After removal of gastric fluid the samples were transferred to intestinal fluid.
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TABLE

vm

EFFECT OF FORMALDEHYDE ON THE

% OF

PENTOBARB ITURIC

ACID EXTRACTED FROM MICROCAPSULES EXPOSED TO
INTESTINAL FLUIDS*

Formaldehyde
(ml.)

after 1 hr.

after 1 /2 hr.

-

-

- - - -

1

sample not collectable

2

sample not collectable

4

27.3

38.8

6

24.4

36.3

8

23.7

37.3

10

28. 3

32.9

20

27.3

40.5

*All values expressed as % of total pentobarbituric acid found
in microcapsules.
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TABLE IX
EFFECT OF FINAL pH ON THE

% OF PENTOBARBITURIC ACID

EXTRACTED FROM MICROCAPSULES EXPOSED T O
GASTROINTESTINAL FLUIDS*

Final pH

after 1 /2
hr. in
gastric
fluid

after 1
hr. i n
intestinal
fluid

after 2
hrs. i n
intestinal
fluid

total in
gastric and
intestinal
fluids

6. 5

27.0

14.7

23.5

50.5

7.0

23.7

28.4

29.3

53.0

7. 5

29. 4

13. 1

22.4

51. 8

8.0

28.6

17.7

27.2

55.8

8.8

36.7

33.7

36.0

72.7

.,,
"'All values expressed as
in microcapsules.

% of total

pentobarbitur ic acid found

Note: After removal of gastric fluid the samples were transferred to intestinal fluid.
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TABLE X
EFFECT OF FINAL pH ON THE% OF PENTOBARBITURIC ACID
EXTRACTED FROM MICROCAPSULES EXPOSED TO
INTESTINAL FLUID*

Final pH

a fter 1 / 2 hr.

a fter 1 hr.

6. 5

27.5

28. 5

7.0

22.4

24.9

7. 5

26.2

31. 9

8.0

25. 5

29.0

8.8

31. 4

33. 9

*All values

expressed as
in microcapsules.

% of total pentobarbituric acid found
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to gastric and intestinal fluids the per cent of acid released at pH 7. 0
was less than that released at pH 6. 5,

Thereafter, a gradual increase

from the low at pH 7. 0 was noted throughout the remainder of the
series.
Table IX indicates that , in assays carried out after one and two
hour periods on samples transferred from gastric fluid to intestinal
fluid, the per cent of pentobarbituric acid extracted was erratic, with
a slight tendency to increase as the final pH was increased.

Table IX

also shows, however, that the overall per cent extracted increased with
increasing final pH

(

EFFECT OF TWEEN 20 ON MICROCAPSULES
Luzzi and Gerraughty (18) showed that Tween 20 in concentrations
of 2% completely inhibited the encapsulation of mineral oil; it was
thought that the orientation of Tween 20 molecules at the oil-water
interface acted to prevent shell forming coacervate droplets from becoming oriented at the interface of the oil.

The preparation of a

series of microcapsules was undertaken in an attempt to establish
the effect on microencapsulation of Tween 20 in systems employing
solid rather than liquid particles.
In this series the per cent of Tween 20 included in the aqueous
phase was varied from zero to O. 0142%, the starting pH was 6. 0, the
starting temperature was 40°C., 8 Gm, of pentobarbituric acid were

(

TABLE XI
EFFECT OF TWEEN 20 ON THE% OF PENTOBARBITURIC ACID
EXTRACTED FROM MICROCAPSULES EXPOSED TO
GASTROINTESTINAL FLUIDS*

after 1/2
hr. in
gastric
fluid

after 1
hr. in
intestinal
fluid

after 2
hrs. in
intestinal
fluid

34.8

19. 2

26.3

61. 1

0.0001

35.0

17. 5

26.8

61. 8

0.0002

33.9

18. 5

27.0

60 .9

0.0006

32.7

20. 1

28.3

61. 0

0.0071

34.4

19. 7

28.2

62.6

0.0142

40.7

20. 0

26. 1

66.8

Tween 20
(%)

(

*An values expressed as
in microcapsules

% of

total in
gastric and
intestinal
fluids

total pentobarbituric acid found

Note: After removal of gastric fluid the samples were transferred to intestinal fluid.
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included, a volume of 10 ml. of formaldehyde solution was added, and
the final pH was 7. 5.

Table XI shows that under these conditions there

was no significant change in the per cent of pentobarbituric acid released, with the exception that, at the highest concentration of Tween 20,
there seemed to be an increase in the per cent of acid released.

EFFECT OF DARVAN 7 ON MICROCAPSULES
Since the solid particles of pentobarbituric acid tended to settle
out of suspension and were at times difficult to disperse, the dispersing agent Darvan 7 was added to three separate series.

Also, since

preliminary work indicated that Darvan 7 was basic {pH 8. 5-9. 0) in the
concentrations used, it was desirable to determine what effects changing pH would have on the activity of the dispersant.

The three series

differed in that the lowest pH values employed were 4. 0, 4. 8, and 3. 5.
The samples of Table XII were prepared in an identical manner
to those in the Tween 20 series, the only difference being that Darvan
7 rather than Tween 20 was added.

At the lowest concentrations of

Darvan 7 there seemed to be less acid extracted by gastrointestinal
fluids than even those samples prepared with no dispersant; thereafter,
the per cent of acid released became greater with increasing additions
of Darvan 7.
Where the samples of Table XIII correspond to the Darvan 7 concentrations of those in Table XII, they are identical , with the exception

(

TABLE XII
EFFECT OF DARVAN 7 ON THE% OF PENTOBARBITURIC ACID
EXTRACTED FROM MICROCAPSULES EXPOSED TO
GASTROINTESTINAL FLUIDS*

Darvan 7
(%}

after 1/2
hr. in
gastric
fluid

after 1
hr. in
intestinal
fluid

aft er 2
hr s. in
i ntestinal
fluid

total in
gastric and
intestinal
fluids

34.8

19.2

26.3

61. 1

0.0195

,30. 2

18.4

24.6

54.8

0.0290

35. 0

20. 1

25.6

60. 6

0.0580

39. 1

22. 1

2 7. 1

66.2

o. 1160

34.7

19.7

28.1

62.8

0.1450

43.0

21. 5

26.2

67.2

0.1740

38.0

23. 1

30.7

68.7

*All values expressed as
in microcapsules.

% of

total pentobarbituric acid found

Note: After removal of gastric fluid the samples were transferred to intestinal fluid.
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TABLE
EFFECT OF DAR VAN 7 ON THE

xm

% OF

PENTOBARBITURIC ACID

EXTRACTED FROM MICROCAPSULES EXPOSED TO
GASTROINTESTINAL FLUIDS*

after 1 /2
hr. in
gastric
fluid

after 1
hr. in
intestinal
fluid

after 2
hrs. in
intestinal
fluid

total in
gastric and
intestinal
fluids

42.2

21. 7

25.9

68.8

0.029

43.5

21. 2

25.7

69. 2

0. 116

45.3

16.3

24.7

70. 0

o. 174

48.5

28.4

30.7

79. 2

Darvan 7
(%)

(

*All values expressed as
in microcapsules.

% of total pentobarbituric acid found

Note: After removal of gastric fluid the samples were transferred to intestinal fluid.
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that the lowest pH in the former was 4. 8 rather than 4. 0.

Table XIII

shows that there was a greater release of pentobarbituric acid as the
concentration of Darvan 7 was increased and also that all of the samples of Table XIII released a greater percentage of acid than the
corresponding members of Table XII.
All of the samples within the series found in Table XIV were prepared in a manner similar to those of the Tween 20 group above with
the exception that the lowest pH was at pH 3. 5 rather than at 4. 0.
Table XIV shows that samples were not collectable until the second increment of Darvan 7 had been added; with the addition of the second
increment of the dispersant, they became collectable.

Increases in

(
the concentration of Darvan 7 beyond the point at which the samples
became collectable could not be studied.

FORMULATION OF FAST AND SLOW RELEASE MICROCAPSULES
Using the information gathered from Tables I through XII, an
attempt was made to formulate microcapsules which would release all
or nearly all of the pentobarbituric acid which they contained.

An

attempt was also made to formulate microcapsules which would retain
more than 50% of their original content of acid after 2. 5 hours exposure to gastrointestinal fluids.

Samples of both formulations were

prepared and they were subjected to the gastrointestinal fluids, as
previously described.

TABLE XIV
EFFECT OF DARVAN 7 ON THE% OF PENTOBARBITURIC ACID
EX TRAC TED FROM MICRO CAPSULES EXPOSED TO
GASTROINTESTINAL FLUIDS*

Darvan 7
(%)

(

- -

-

after 1 /2
hr. in
gastric
fluid

after 1
hr. in
intestinal
fluid

sample not collectable

after 2
hrs. in
intestina l
fluid

total in
gastric and
intestinal
fluids

- - - - - - - - - - -

-

- -

--

0.029

sample not collectable

0.058

39. 8

24.6

32.5

72.3

o.

116

40.4

23.4

30. 3

70. 7

o. 174

41. 3

32. 1

36.7

78. 0

0.232

41. 0

22.2

29.9

70. 9

*All values

expressed as
in microcapsules.

% of

-

total pentobarbituric acid found

Note: After removal of gastric fluid the samples were transferred to intestinal fluid.
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Samples for fast release microcapsules were prepared using the
following conditions: the starting pH was 5. 0, the starting temperature
was 34 °c.

,

the ratio of pentobarbituric acid to encapsulating agents

was 20/6, four milliliters of formaldehyde solution was added for each
100 ml. of 3% gelatin solution and, the final pH was 8. 8.
Sampil.es for slow release microcapsules were prepared using the
following conditions: the starting pH was 6. O; the starting temperature
was 37°C.; the ratio of acid to encapsulatin g agents was 4/6; eight
milliliters of formaldehyde solution was added; and the final pH was

6. 5.
The results of assays for fast release microcapsules revealed that

(
4 7. 3% of the drug was extracted after one-half hour exposure to gastric
fluid, 30. 1 % after being transferred to intestinal fluid and remaining
immersed for one hour, 31. 2% extracted after two hours in intestinal
fluid, for a total of 78. 5% released after two and one-half hours exposure to gastrointestinal fluids.
The results of as says for slow release microcapsules revealed
that 37. 7% of the drug was released during one-half hour exposure to
gastric fluid, 16. 0% released after being transferred to intestinal
fluid and being immersed for one hour and 21. 5% extracted after two
hours in contact with intestinal fluid, for a total of 56. 2% released
after two and one-half hours exposure to gastrointestinal fluids.
In the fast release samples there was a difference of 1. 1 % in total

46
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per cent acid extracted between the one and two hour exposure periods
to intestinal fluid, whereas there was a difference of 5. 5% acid extracted under the same conditions for the slow release samples,
Although the per cent of pentobarbituric acid released after the
two and one-half hour assay period fell somewhat short of the goal of
this experiment, there seemed to be a significant difference in the
per cent of acid released between the two types of samples.

It should

be pointed out that although the results found in Table I indicate that a
starting pH of 6. 5 was optimum for slow release microcapsules, a
pH of 6. 0 was utilized since the over-all difference between the values
was not significant and since the acid is less soluble at lower pH

(

values.

MICRO-PHOTOGRAPHY OF MICROCAPSULES
It is the intent of this section to clarify (through photographs) the
action of the gelatin-acacia complex as an encapsulating agent as well
as to underscore the effects of Tween 20 and Darvan 7 on microencapsulation.

The solid, in this case, pentobarbituric acid, was encap-

sulated in the prescribed manner and photomicrographs were taken of
the product after filtration and prior to drying .
The equipment employed consisted of an Exakt a VX-1la

(o)

0

camera

Exakta Camera Co., Bronx River Road, Bronxville, New York

47
mounted on a Spencer binocular microscopeP.
4 seconds using Panatomic-x film by Kodak.

All exposures were for
The magnification in

each photograph was determined by comparison, at similar conditions,
to a standard ruled slideq.

A magnification statute accompanies each

photograph.
Photograph I shows a dispersion of pentobarbituric acid particles
in a 3% gelatin solution.
dispersed.

It can be seen that the particles are quite well

The slight haze surrounding the particles is due to the

movement of the particles probably caused by evaporation of water.
Photograph II is typical of groups of microcapsules found when
there is an optimum relationship between solid particles and encap-

(

sulating agents.

All particles are encapsulated and it can be seen that,

in some cases, the capsules have fused together.

It is also apparent

that in some cases small groups of solid particles are encompassed
by a single capsule.
Photograph III depicts both filled and unfilled microcapsules.
The encapsulated solid in this case is DDT.

No explanation of cap-

sule shape can be given at this time.
Tween 2 0 (0. 0071 %) was added to the system of Photograph IV.
Both encapsulated and unencapsulated particles are visible.

(p) American Optical Company, Buffalo 15, New York
(q) Bousch and Lomb Optical Co., Rochester, New York
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Photographs of systems containing less surfactant were prepared and,
although not shown, suggested a progressive interferrence with encapsulation as Tween 20 concentration was increased.
Photographs V, VI and VII are of systems containing 0. 019%,
0. 029% and 0. 116% of Darvan 2 respectively.

In Photograph V it cq.n

be seen that the particles were not well dispersed and that large
groups of particles seem to have gathered together to form a large
group or groups of capsules.

This may account for the decreased re-

lease of pentobarbituric acid at this concentration of Darvan 7 (Table
XII, p. 41).
Photograph VI was made from microcapsules to which 0. 029%

(

Darvan 7 had been added and shows elongated capsules filled with
solid particles.

The elongation of capsules seemed to be typical when

moderate quantities of this dispersant were used.

A comparison of the

shell thickness of the overall capsules to the shell thickness of capsules
of previous photos would seem to indicate that high concentrations of
the dispersant tent to decrease wall thickness.
Photograph VII was made of microcapsules containing 0. 116%
Darvan 7.

Although the enlargement in this case was less than in

preceding ones, it can be seen that the solids are in smaller groups,
that the capsule shells are quite thin, and that some capsules are not
filled.
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Photograph I
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Photograph IV
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Photograph V
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Photograph VI
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IV DISCUSSION

Microenc apsulation of finely divided solids occurs when
c6acerv a te dropl ets fo r m about the s o lid particles, but the manner
i n whi ch the a c tual encapsulation o c c urs is not clear.

The following

are two pos s i b l e methods by which encap sula tion may occur.

First,

the capsule fo rma t i on may occur in one step, that is, only one coacerIf this is

v ate droplet m a y be required to encompass each particle.

the case, o ne woul d sus pect that the size of the particle or the method
of prepar.at i on of the droplet would be of major consideration.
S e con d, the capsule formation may occur as the result of the
agglome r ation o f m a ny small coacervate droplets about the solid particles
to form a clo se d c a psu l e which may or may not h e porous.
In both cases the coacervate capsule may be considered to b e
prior to dr ying, made up o f hydrated • o lloi~al rna,;eri.al.

When the

microcapsule shells are dehydrated, the thickness of the coacervate
shell is redu c ed and the whole particle is reduced in size. although
there is no cha nge i n the size of the encapsulated solid.
P oss ibl e applications

of this form of mi croencapsulation to

pharmac euticals l ed to an interest in the possibility of encapsulating
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200..).l

Photograph VII
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solids and to the evaluation of some aspects of the system used to
prepare the capsules.
method include:

The solids which were encapsulated by this

Colloidal sulfur, special flowers of sulfur, aspirin

anhydride, acetophenetidin, barbituric acid, lycopodium spores, DDT,
pentobarbituric acid, and carbon black.

Pentobarbituric acid was em-

ployed for the collection of all quantitative data presented in this
thesis.

The specific variables chosen for study included starting pH,

starting temperature, ratio of encapsulated material to encapsulating
materials, quantity of denaturant, and the final pH.
It was desirable to obtain some degree of controlled variation of
these properties, and in this respect all samples within a given group

(

were prepared utilizing the same conditions with the exception that
one of the above variables was altered.

However, comparison of re-

sults between series is not valid since factors other than the indicated
variable may have been altered.

It should be explained that at no time

during the preparation of a given series did any of the variable conditions chosen for examination exceed the limits set forth in the series
designed to examine the effects of the variable.
The method of Luzzi and Gerraughty (18) was chosen since this
investigator was familiar with it and since it offered the opportunity
to evaluate a unique system for the microencapsulation of solids.
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EFFEg OF STARTING

£!i. ON

MICROCAPSULES

A study of the effect of starting pH on the per cent of pentobarbituric acid released from the various microcapsule samples which had
been exposed to gastric and intestinal fluids (Table I, p. 25) reveals that
the quantity of acid released over a 2. 5 hour period did not differ significantly.

When the samples were exposed only to intestinal fluid

(Table II, p. 27) for a one hour period, there again seemed to be no
significant difference in the protection offered, however, examination
of the data for one-half hour periods in both gastric fluid and intestinal
fluid indicates a greater variation in the per cent of total acid released.
The per cent extracted after one-half hour in intestinal fluid is
probably the least reliable of all the data collected, since during this
time interval there was no digestion of protein and the only probable
reactions were a combination of hydration and leaching.

In light of the

above, it would seem likely that as hydration of the shell approached
completion, the results would become more reliable as well as more
reproducible.

This was found to be the case with samples exposed

only to intestinal fluid for one hour periods.

This supposition was

further substantiated by the assay results obtained from the consecutive immersions of samples in gastric and intestinal fluids.
The per cent pentobarbituric acid extracted after immersions in
gastric fluid for one-half hour indicated no clear trend.

It was ex-

pected that the highest per cent releases would occur at pH 5. 0 and
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pH 7. 0 and although this was the case, the difference between these
two values and the intervening values was not of such a nature that
a definitive judgement could be made.

At a starting pH of 5. 0, coa-

cervation was probably partially complete prior to the addition of the
solid particles, in which case the ratio of encapsulated to encapsulating
material would have, in effect, been increased.

It is quite clear from

Tables V and VI (pp. 31 and 32) that as this ratio increases the per
cent of solid released increases.
At a starting pH of 7. 0 the solubility of pentobarbituric acid, as
its salt, is theoretically greater than at the other pH values. Therefore, it is possible to suggest interference with the microencapsula-

(

tion process. at pH 7. 0, by virtue of the presence of too high a salt
concentration (10).

The possibility also exists that, once converted

to its solubilized form, the active constituent could have been adsorbed or entrapped by the gelatin or acacia or both and subsequently
released to the gastric fluid more rapidly than if solubilization had
not occurred.

EFFECT OF STAR TING TEMPERATURE ON MICROCAPSULES
As may be seen fro1n Tables III and IV, the relative position of
each sample, as to the per cent of pentobarbituric acid extracted, was
found to remain the same after all time periods.

A maximum in per

cent of acid extracted was found when the starting tempE;irature was

(
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34°C.

It may be that, at this temperature, the system of gelatin and

acacia was sufficiently viscous to inhibit the free movement of either
the colloidal particles, which is necessary for coacervation, or of the
formed coacervate droplets, which may be necessary if microencapsulation is to occur.
After a minimum was reached, an increase was observed in per
cent of total acid extracted as the starting temperature was increased.
This was probably due to the salt-like effect of the greater quantity of
acid in solution at the higher temperatures.

It could also be due, in

part, to the entrapment by the encapsulating medium of the solubilized acid, thus causing faster initial release rates.

(

The latter specu-

lation is not, however, substantiated by the results shown in Table IV
(p. 29), when these results are compared to the results of similar
extraction procedures.
In light of the above discussion, it is possible to suggest that the
lower per cent release of acid at the starting temperature of 37°C.
was due to a combination of (sufficiently low) viscosity and relatively
low concentration of acid in solution; and converse reasoning would
probably hold for the higher per cent release at 34°c.

l
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EFFECT OF THE RA TIO OF PENTOBARBITURIC ACID TO
ENCAPSULATING MATERIALS
The results of this study indicate that, within the range of ratios
used, pentobarbituric acid was extracted from microcapsules m ore
rapidly, in all cases, as the ratio of acid to encapsulating agents was
increased.
A comparison of the per cent of pentobarbituric acid extracted in
gastric fluid with the per cent released after the one and two hour exposures to intestinal fluid (Table V, p. 31) indicates that the low ratio
samples release a higher percentage of remaining acid with increasing
time.

(

It would be interesting to determine whether or not the low

ratio samples would continue to release a greater percentage of the
remaining acid with the passage of time, however, the available data
precludes such a determination.
These results would, however, seem to underscore the theory
of microencapsulation in which many coacervate droplets agglomerate
about the particle.

In order to conform to this theory, the pre para-

tions with lower ratios would probably have multiple layers of droplets while preparations with higher ratios would have fewer layers.

EFFECT OF FORMALDEHYDE ON MICROCAPSULES
The effect of formaldehyde on the permeability of microcapsules
was determined by varying the quantity of formaldehyde solution added to the system during the preparation of samples.

When no
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formaldehyde solution was added, and with quantities of up to 2 ml.
per 100 ml. of gelatin solution, the samples seemed to melt together
either on reaching room temperature or upon drying at 40°C.

with the

addition of 4 ml., or more, of formaldehyde soluti on the samples
maintained a typical appear :;.nce throughout the preparati on procedures.
Because formaldehyde is a d enaturant of protein, it is essential to
this method of microencapsulation, a fact that seems to be · substantiated by the difficulty encountered in collection of samples to which little
or no formaldehyde was added.
The release of acid from capsules to which 8 ml. of formaldehyde
solution had been added was at a minimum when exposed to gastro-

(

intestinal fluids.

When the volume of formaldehyde solution was varied

by 2 ml. in either direction, an increase in the quantity of acid extracted was observed.

As the quantity of formaldehyde solution was varied

further, a greater increase in the per cent of re leased acid was observed.
The increase in the per cent of acid released at the low formaldehyde concentration was probably due to two factors both of which
could result from inadequate denaturization.

First, the gelatin-

acacia shell might not have been sufficiently denatured, thus promoting a partial solubilization of coacervate droplets d ur i ng the washi:pg
procedure to create a thinner or more porous shell; and second, the
droplets might not have been solubilized during washing but may
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have been made less impervious to the action of gastrointestinal fluids
through lack of adequate denaturization.
Microscopic observations of samples, prior to drying, throughout
the entire range of this series indicate no appreciable difference in the
size of the microcapsules.

This observation would seem to suggest

that an increased susceptibility to gastrointestinal fluids was responsible for the rise in per cent of acid extracted from samples to which
small quantities of formaldehyde had been added.
The increased per cent of acid that was extracted when greater
volumes of formaldehyde solution were added to the system was
probably due to a cracking of the capsule shell on drying.

(

This

cracking, which resulted in porous capsules, may have resulted
from excessive denaturization.

EFFECT OF

FINAL~

ON MICROCAPS"gLES

The samples of this series seemed to show a tendency for the
microcapsules to give up more of the encapsulated solid as the final
pH was increased,

Since a high final pH acts to fix the coacervate

droplets in place about the particle to be encapsulated and since pentobarbituric acid is quite insoluble at pH 6. 5, it was expected that a
relatively high per cent of acid would be extracted at this pH.

It was

also expected that because of the solubility of the acid at high pH
values, a maximum per cent extracted would be observed at a final
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pH 8. 8.

The latter expectation was borne ou t i n t h e results found

in Table IX (p. 3 6 ).
The re s ults shown in this table w ould seem to indicate that capsules prepared a t a fi na l pH 7 . 0 were extracted to a lesser degree by
gastric fluid and t o a greater degree by intestinal fluid than th e rest
of the series, with the exce pt ion of the final sample.
At final pH 6. 5 the capsule shells appea r to h a ye been broken
down more re a dily by gastri c fluid than at pH 7. 0.

The possibility

also exists that at pH 7. 0 the c ap s u l es were more firmly fixed and
less porous than at pH 6. 5 .

It i s also possible that a t pH 7. 0 the cap1

sule s were diges te d e xtens ively by the gastric fluid - - to such a degree

(

as to eventually allow fas t er l eeching eventually, but not so exce s sively as to expose the solid complete l y -- thus making the capsule s hells
much more perm e a ble to extracti on when placed in int e s tinal fluids .
The higher r ates of extra c t ion at fina l pH values above 7. 0 could
have resulted from an inc reased acid s o lubility; and the retenti on of
the solubilized acid by the capsul e wall during the drying procedure,
followed by rapi d re l ease to the extraction fluids.

At final pH 8 . 8

the quantity of a cid solubilized is probably much greater than a t other
values us e d; t h e salt formed a t pH 8. 8 may hav e acted to reve r se the
coacervation proc ess causing a general weaken ing of the capsul e shell
and resulting in g reater quantities of extracted.

(
V. CONCLUSIONS

On the basis of the previous work and the results reported in
this study, the following conclusions may be drawn 1.

Solids, such as pentobarbituric acid, which are relatively

insoluble in aqueous systems, can be successfully encapsulated and
well protected.
2.

In the coacervation process used, starting pH values below

5. 0, microencapsulation of pentobarbituric acid is inhibited.
3.

(

The strength of the capsule shell can be controlled by

changing, either individually or combinations of: the starting temperature, the ratio of encapsulable to encapsulating materials, the quantity
of formaldehyde added, and the final pH.
4.

Surfactants or dispersants, in sufficient concentration, in-

crease the rate of release of encapsulated solids to gastrointestinal
fluids.
5.

The end results of encapsulation may be elucidated by the

use of microphotographic techniques.
In order to clarify some of the aspects of this problem, further
work in the following areas is recommended.
1.

l

Experiments should be designed that would apply the results
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obtained in this investigation to the for mation of time re l ease me dication.
2.

Controlled combinations of t he variables tested here should

be examined .
3.

Other prob l ems of encapsulation by this method , suc h as

lowest encapsulatin g pH, shoul d be examined more th o r oughly .
4.

In order to de t ermi ne the effect o f the order of m ixing , other

surfactants and deflocculants as we ll as those already used , shou l d
be introduced at v ar i ous points duri ng the preparation of microcapsules.
5.

(

(

Encapsulat io n s hould be attempted using denaturants , such as

alcohol, rather than fo rmaldehyde.

VI.

(
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